Therapeutic research with incapacitated subjects must be submitted for review to an accredited MREC. See also the CCMO-note therapeutic versus non-therapeutic research. In the case of research with a medicinal product the following generally applies:

  • phase I research is non-therapeutic;
  • phase II, III en phase IV research are therapeutic.